46. Malignant rheumatoid arthritis Clinical trials / Disease details


Clinical trials : 4,356 Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01179971
(ClinicalTrials.gov)
December 20084/8/2010n-3 and n-6 Fatty Acids in Rheumatoid ArthritisIncorporation of n-3 Long Chain Polyunsaturated Fatty Acids and Gamma Linolenic Acid in Plasma Lipids, Cholesteryl Esters, and Erythrocyte Membranes and Their Influence on Disease Activity in Patients With Rheumatoid ArthritisRheumatoid ArthritisDietary Supplement: Fish oil, gamma-linolenic acidCharite University, Berlin, GermanyUniversity of JenaCompleted18 Years80 YearsBoth60Phase 2NULL
2NCT00004420
(ClinicalTrials.gov)
September 199418/10/1999Study of Gammalinolenic Acid for Juvenile Rheumatoid ArthritisJuvenile Rheumatoid ArthritisDrug: gamma-Linolenic acidFDA Office of Orphan Products DevelopmentUniversity of Massachusetts, WorcesterCompleted1 Year15 YearsBoth50N/ANULL